Global trends and gaps in pharmacogenetic clinical trials: A cross-sectional analysis of ClinicalTrials.gov registrations. [PDF]
Aldurdunji M +3 more
europepmc +1 more source
Pharmacogenomics of CYP2D6, CYP2C19, CYP2C9, and Clinical Determinants of Fluoxetine-Norfluoxetine Pharmacokinetics in Real-World Clinical Conditions. [PDF]
de la Cruz CG +5 more
europepmc +1 more source
Genetic variability and response to sertraline in pediatric populations: a review on pharmacogenetics, pharmacokinetics, and the risk of adverse events. [PDF]
Gándara-Mireles JA +7 more
europepmc +1 more source
Population-based study of pharmacogenetics and pharmacokinetics in Southern African patients with multidrug-resistant tuberculosis (PoPG): a protocol for the Namibian cohort. [PDF]
Boois L +14 more
europepmc +1 more source
Evaluating genotype-treatment interactions for high-risk medications in British general practice: a retrospective cohort study using UK Biobank. [PDF]
Mokbel K +4 more
europepmc +1 more source
Hypertension pharmacogenetics and limitations in Africa - a focus on the ACE, AGTR1 and CYP2C9 genes. [PDF]
Gomera RT +4 more
europepmc +1 more source
Pharmacogenetics in Tuberculosis-HIV Coinfected Populations: A Systematic Review of Genetic Variants Influencing Antiretroviral and Anti-Tuberculosis Drug Response. [PDF]
Hardi H +3 more
europepmc +1 more source
Cost-Effectiveness of Pre-emptive DPYD Genotyping Compared to Standard of Care Among Patients Receiving Fluoropyrimidine-Based Anti-cancer Treatment in Australia. [PDF]
Glewis S +12 more
europepmc +1 more source
Pharmacogenetics and the Response to Antidepressants in Major Depressive Disorder. [PDF]
Bertollo AG, Mocelin R, Ignácio ZM.
europepmc +1 more source
Pharmacogenetics in ICU patients: a short introduction. [PDF]
Hunfeld NGM, Ercole A, Swen JJ.
europepmc +1 more source

